Replies to post #7284 on SiNtx Technologies Inc (SINT)

[BooDog]

FDA's drug evaluation component suffers staffing woes

The Food and Drug Administration’s drug approval function is being hindered by hundreds of staff vacancies at FDA’s Center for Drug Evaluation and Research.
By FederalSoup Staff
Nov 02, 2016

The Food and Drug Administration’s drug approval function is being hindered by hundreds of staff vacancies at FDA’s Center for Drug Evaluation and Research, the Washington Post reports.

The reason, according to CDER Director Janet Woodcock, is that pharmaceutical companies pay about twice as much for that talent. At the end of September, her agency had 711 vacancies, about one out of every eight slots at the organization.

To fill in those gaps, CDER continues to use contract workers and employees borrowed from other parts of FDA, the article noted.

https://federalsoup.com/articles/2016/11/02/agg-fda-drug-evaluation-component-suffers-staffing-woes.aspx

===========================

So how about that. I have a couple that have been waiting seemingly forever (a few months :-) ) for FDA responses.

So, literally, we could see our answer any day.

Go AMDA!!

Does it creep anyone out that our FDA peoples are being sucked into these companies because they know weaknesses or ways to potentially hide things? nah, that wouldn't happen. Or the ex FDA new guy hired into the company has easy ears still inside the FDA when it's close to decision time? Like that hasn't already happened.